Cambridge Investment Research Advisors
AMGN icon

Cambridge Investment Research Advisors’s Amgen AMGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39M Sell
107,825
-1,502
-1% -$514K 0.09% 221
2026
Q1 		$38.5M Buy
109,327
+1,721
+2% +$614K 0.1% 199
2025
Q4 		$35.2M Buy
107,606
+2,177
+2% +$691K 0.09% 211
2025
Q3 		$29.8M Sell
105,429
-2,988
-3% -$867K 0.08% 248
2025
Q2 		$30.3M Buy
108,417
+171
+0.2% +$48.4K 0.09% 224
2025
Q1 		$33.7M Sell
108,246
-26
-0% -$7.68K 0.11% 173
2024
Q4 		$28.2M Sell
108,272
-553
-0.5% -$164K 0.09% 200
2024
Q3 		$35.1M Sell
108,825
-927
-0.8% -$303K 0.12% 169
2024
Q2 		$34.3M Sell
109,752
-11,418
-9% -$3.35M 0.13% 151
2024
Q1 		$34.5M Buy
121,170
+173
+0.1% +$50.6K 0.13% 143
2023
Q4 		$34.9M Buy
120,997
+992
+0.8% +$270K 0.15% 134
2023
Q3 		$32.3M Buy
120,005
+9,106
+8% +$2.27M 0.15% 124
2023
Q2 		$24.6M Buy
110,899
+961
+0.9% +$223K 0.11% 182
2023
Q1 		$26.6M Buy
109,938
+15,936
+17% +$3.91M 0.13% 161
2022
Q4 		$24.7M Buy
94,002
+557
+0.6% +$149K 0.13% 162
2022
Q3 		$21.1M Buy
93,445
+717
+0.8% +$174K 0.12% 181
2022
Q2 		$22.6M Buy
92,728
+968
+1% +$237K 0.12% 173
2022
Q1 		$22.2M Buy
91,760
+1,668
+2% +$383K 0.1% 202
2021
Q4 		$20.3M Buy
90,092
+1,575
+2% +$332K 0.09% 214
2021
Q3 		$18.8M Buy
88,517
+4,830
+6% +$1.11M 0.09% 212
2021
Q2 		$20.4M Buy
83,687
+3,938
+5% +$969K 0.1% 212
2021
Q1 		$19.8M Buy
79,749
+470
+0.6% +$112K 0.11% 197
2020
Q4 		$18.2M Sell
79,279
-3,292
-4% -$759K 0.11% 193
2020
Q3 		$21M Sell
82,571
-4,731
-5% -$1.17M 0.14% 157
2020
Q2 		$20.6M Buy
87,302
+1,812
+2% +$413K 0.15% 141
2020
Q1 		$17.3M Sell
85,490
-552
-0.6% -$121K 0.17% 131
2019
Q4 		$20.7M Buy
86,042
+4,566
+6% +$1.01M 0.16% 132
2019
Q3 		$15.8M Sell
81,476
-264
-0.3% -$50.7K 0.14% 157
2019
Q2 		$15.1M Buy
81,740
+4,815
+6% +$862K 0.14% 159
2019
Q1 		$14.6M Sell
76,925
-6,307
-8% -$1.2M 0.14% 152
2018
Q4 		$16.2M Buy
83,232
+793
+1% +$155K 0.18% 121
2018
Q3 		$17.1M Buy
82,439
+5,403
+7% +$1.06M 0.16% 139
2018
Q2 		$14.2M Sell
77,036
-5,666
-7% -$1M 0.15% 139
2018
Q1 		$14.1M Buy
82,702
+4,554
+6% +$836K 0.16% 130
2017
Q4 		$13.6M Buy
78,148
+1,354
+2% +$240K 0.16% 135
2017
Q3 		$14.3M Buy
76,794
+3,935
+5% +$697K 0.19% 108
2017
Q2 		$12.5M Buy
+72,859
New +$11.9M 0.18% 108
2016
Q4 		– Sell
-43,593
Closed -$7.27M – 1688
2016
Q3 		$7.27M Buy
+43,593
New +$7.37M 0.14% 139
2016
Q2 		– Sell
-41,707
Closed -$6.25M – 1577
2016
Q1 		$6.25M Buy
41,707
+3,292
+9% +$489K 0.14% 136
2015
Q4 		$6.24M Buy
+38,415
New +$6.04M 0.15% 131
2015
Q3 		– Sell
-32,676
Closed -$5.02M – 1455
2015
Q2 		$5.02M Sell
32,676
-283
-0.9% -$45.3K 0.14% 151
2015
Q1 		$5.27M Buy
32,959
+616
+2% +$97K 0.15% 142
2014
Q4 		$5.15M Buy
32,343
+3,635
+13% +$566K 0.16% 125
2014
Q3 		$4.03M Buy
28,708
+239
+0.8% +$31.2K 0.12% 168
2014
Q2 		$3.37M Sell
28,469
-6,788
-19% -$786K 0.12% 164
2014
Q1 		$4.35M Buy
35,257
+1,017
+3% +$123K 0.16% 124
2013
Q4 		$3.91M Buy
34,240
+2,864
+9% +$326K 0.16% 131
2013
Q3 		$3.51M Buy
31,376
+3,510
+13% +$381K 0.15% 137
2013
Q2 		$2.75M Buy
+27,866
New +$2.89M 0.14% 148

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Cambridge Investment Research Advisors's AMGN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $514K and leaving 107,825 shares worth $39M. The position accounts for 0.09% of the portfolio, ranked #221.

Cambridge Investment Research Advisors first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. 1,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cambridge Investment Research Advisors held 107,825 shares of Amgen worth $39M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,502 Amgen shares in Q2 2026, an estimated $514K.
  • Amgen made up 0.09% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #221 holding.
  • Cambridge Investment Research Advisors first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • 1,195 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.